• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them
NCT ID: NCT03864809
Last Updated: 2019-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2019-06-01
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Disturbances in Dermatology Patients
NCT03903263
Comparison Across Multiple Types of Sleep Deprivation
NCT04211506
Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology
NCT00696397
Development and Evaluation of a Sleep-coaching Program
NCT02896062
Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis
NCT05102474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
insomnia, the most common sleep disorder, is a clinical condition defined as difficulties falling asleep and/or maintaining sleep and/or poor sleep quality despite adequate opportunity for sleep resulting in significant daytime impairment.
The development of insomnia in healthy populations has a bi-directional relationship with psychological factors such as anxiety, depressive symptoms and stress, and may in clinical populations also be associated with physical symptoms, such as pain. the physical symptoms in psoriasis, such as itch, one would expect a higher prevalence of sleep disturbance in this patient group. On the other hand Sleep disturbance is common also in patients with atopic dermatitis (AD). Patients with AD often have sleep disturbances due to pruritus.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
psoriasis patients
sleep disturbance
sleep disturbance
we observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group
atopic dermatites patients
sleep disturbance
sleep disturbance
we observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group
control
sleep disturbance
sleep disturbance
we observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleep disturbance
we observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amani Mahmoud Abdelmohsen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
radwa bakr, lecturer
Role: STUDY_DIRECTOR
Assiut University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Jensen P, Zachariae C, Skov L, Zachariae R. Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol. 2018 Dec;179(6):1376-1384. doi: 10.1111/bjd.16702. Epub 2018 Aug 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SL disturb in psoriasis atopy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.